These data are in agreement with the largest study conducted to date that reported a frequency of 39% for nuclear ERβ1 expression in ERα-positive invasive breast cancers using the same antibody as was used in this study (PPG5/10) [46]. The gene discussed is ESR1; the disease is invasive breast carcinoma.